Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
13.22
+1.24 (10.35%)
At close: Jun 26, 2026, 4:00 PM EDT
13.21
-0.01 (-0.08%)
After-hours: Jun 26, 2026, 7:56 PM EDT
TNXP Employees
Tonix Pharmaceuticals Holding had 142 employees as of December 31, 2025. The number of employees increased by 61 or 75.31% compared to the previous year.
Employees
142
Change (1Y)
61
Growth (1Y)
75.31%
Revenue / Employee
$123,634
Profits / Employee
-$1,037,930
Market Cap
210.74M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| MediWound | 121 |
| Arcturus Therapeutics Holdings | 111 |
| Nkarta | 108 |
| Compugen | 75 |
| NovaBridge Biosciences | 30 |
| AN2 Therapeutics | 21 |
| Outlook Therapeutics | 17 |
TNXP News
- 3 days ago - Tonix Pharmaceuticals initiated with a Strong Buy at Raymond James - TheFly
- 13 days ago - Tonix Pharmaceuticals Holding Slides: Investor presentation - Filings
- 17 days ago - Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026 - GlobeNewsWire
- 20 days ago - Tonix Pharmaceuticals secures second commercial agreement for Tonmya - TheFly
- 20 days ago - Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives - GlobeNewsWire
- 27 days ago - Tonix Pharmaceuticals Holding Slides: Investor presentation - Filings
- 4 weeks ago - Tonix presents data from analysis of opioid use in adults with fibromyalgia - TheFly
- 4 weeks ago - Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting - GlobeNewsWire